Claris collects $118M to take eye drop into pivotal testing next year
Claris collects $118M to take eye drop into pivotal testing next year.
Claris Bio is a ophthalmology company. See today's news for the latest developments.
Company Info
Funding & Investor Relations
Upcoming Milestones & Key Dates
Initial profile created
Clinical Development Pipeline
Recent News
Claris collects $118M to take eye drop into pivotal testing next year.
Novo Holdings-backed Claris Bio emerges with $118M.
Leadership Team
Leadership team
Careers & Job Openings